Senior Business Development Executive, Dr Kathleen Miller, joins Clarity’s team
Sydney, Australia 4 July 2017 – Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce the appointment of Dr Kathleen Miller, a US based experienced business development executive, to Clarity’s team. Dr Miller has over 25 years of experience in the pharmaceutical, medical imaging, and medical device industries,…